Agilon Health (NYSE:AGL) Given New $1.00 Price Target at Robert W. Baird

Key Points

• Agilon Health's price target was significantly reduced from $5.00 to $1.00 by Robert W. Baird, indicating a potential downside of 8.68% from its previous close and maintaining a "neutral" rating.
• Despite mixed analyst ratings, the average price target for Agilon Health is $3.77 with two analysts recommending a sell, ten a hold, and five a buy.
• Agilon Health reported a revenue decline of 5.9% year-over-year and missed earnings expectations, with a loss of ($0.25) EPS for the latest quarter.

Agilon Health (NYSE:AGL - Free Report) had its target price trimmed by Robert W. Baird from $5.00 to $1.00 in a research report released on Thursday,Benzinga reports. The brokerage currently has a neutral rating on the stock.

AGL has been the topic of a number of other research reports. Evercore ISI lowered their target price on Agilon Health from $5.00 to $3.00 and set an "in-line" rating on the stock in a research note on Wednesday, July 9th. JMP Securities restated a "market perform" rating on shares of Agilon Health in a research note on Monday, April 28th. Citigroup upgraded Agilon Health from a "neutral" rating to a "buy" rating and boosted their target price for the company from $3.25 to $5.00 in a research note on Friday, April 25th. Barclays reduced their price target on Agilon Health from $3.00 to $1.50 and set an "underweight" rating for the company in a research report on Wednesday, August 6th. Finally, The Goldman Sachs Group boosted their price target on Agilon Health from $2.50 to $5.00 and gave the stock a "neutral" rating in a research report on Thursday, May 8th. Two analysts have rated the stock with a sell rating, eleven have issued a hold rating and five have given a buy rating to the stock. According to MarketBeat.com, the company currently has an average rating of "Hold" and a consensus price target of $3.58.

Agilon Health Stock Up 2.3%

AGL stock traded up $0.03 on Thursday, reaching $1.14. 603,042 shares of the company's stock were exchanged, compared to its average volume of 7,189,469. The firm has a market cap of $470.37 million, a PE ratio of -1.47 and a beta of 0.14. Agilon Health has a twelve month low of $0.71 and a twelve month high of $6.08. The stock has a fifty day moving average of $1.96 and a 200-day moving average of $3.06.

Agilon Health (NYSE:AGL - Get Free Report) last posted its earnings results on Monday, August 4th. The company reported ($0.25) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.11) by ($0.14). Agilon Health had a negative net margin of 5.35% and a negative return on equity of 66.76%. The company had revenue of $1.39 billion during the quarter, compared to analyst estimates of $1.47 billion. During the same quarter last year, the business posted ($0.07) EPS. Agilon Health's quarterly revenue was down 5.9% compared to the same quarter last year. On average, equities research analysts predict that Agilon Health will post -0.59 EPS for the current fiscal year.

Institutional Trading of Agilon Health

A number of institutional investors have recently modified their holdings of the company. Capital International Investors lifted its holdings in shares of Agilon Health by 72.0% in the fourth quarter. Capital International Investors now owns 22,331,873 shares of the company's stock valued at $42,431,000 after purchasing an additional 9,346,295 shares in the last quarter. Millennium Management LLC lifted its holdings in shares of Agilon Health by 187.8% in the fourth quarter. Millennium Management LLC now owns 7,212,525 shares of the company's stock valued at $13,704,000 after purchasing an additional 4,706,357 shares in the last quarter. Geode Capital Management LLC lifted its holdings in shares of Agilon Health by 2.6% in the second quarter. Geode Capital Management LLC now owns 7,156,466 shares of the company's stock valued at $16,462,000 after purchasing an additional 178,477 shares in the last quarter. Goldman Sachs Group Inc. lifted its holdings in shares of Agilon Health by 6.6% in the first quarter. Goldman Sachs Group Inc. now owns 5,060,333 shares of the company's stock valued at $21,911,000 after purchasing an additional 311,158 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. lifted its holdings in shares of Agilon Health by 8.8% in the first quarter. Charles Schwab Investment Management Inc. now owns 4,939,576 shares of the company's stock valued at $21,388,000 after purchasing an additional 398,027 shares in the last quarter.

About Agilon Health

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.